Executive Summary: Key Legal and Evidentiary Issues

• Scope of the Consent and Capacity Board’s mandate under s. 4(1) of the Health Care Consent Act and whether it improperly based incapacity on disagreement with medical opinion rather than on true inability to appreciate consequences
• Proper interpretation of the second branch of the s. 4(1) capacity test: “ability to appreciate the reasonably foreseeable consequences” of refusing or withdrawing antipsychotic medication
• Weight the Board could lawfully place on the patient’s refusal to accept schizophrenia as the cause of his past criminal conduct and his non-medical reasons for taking medication
• Significance of evidence that the patient planned a gradual dose reduction and would resume medication on relapse as proof of his appreciation of risk
• Interaction between patient autonomy and clinical “best interests,” including whether institutional goals (peace, order, nuisance reduction) can justify a finding of incapacity
• Appellate standard of review for the Board’s legal reasoning, and identification of an extricable error of law in misapplying the s. 4(1) capacity framework

Facts and background

Julius Ohenhen, now 52, has a long history of serious mental health issues intertwined with the criminal justice system. In the 1990s and early 2000s he accumulated a criminal record, including a 2001 sentence for criminal harassment that ended with his involuntary hospitalization under the Mental Health Act for serious persecutory delusions and schizophrenia. His symptoms had manifested in antisocial behaviour such as threats, aggression, telephone harassment, and compulsive letter-writing. In 2007, he was found not criminally responsible on account of mental disorder (NCR), resulting in a detention order by the Ontario Review Board. By 2015, he had progressed to discharge to the community in high-support housing, and by 2019 he obtained an absolute discharge. Since discharge, he remained stable while on antipsychotic medication. Over time, however, he became resistant to continuing the drug regimen, complaining of side effects such as drowsiness and nausea, and believing he never needed medication to remain peaceful. He applied several times to the Consent and Capacity Board to overturn findings that he was incapable of making treatment decisions, and he had previously appealed such a decision to the Superior Court.

Proceedings before the Consent and Capacity Board

Dr. John Klukach had been treating Mr. Ohenhen for four years at the time of the impugned Board hearing and found him incapable of making treatment decisions under s. 4(1) of the Health Care Consent Act. He testified that while his patient could understand basic information about the antipsychotic medication, he was unable to appreciate the reasonably foreseeable consequences of coming off the drug. Dr. Klukach’s clinical view was that mental illness had driven the obsessive and delusional ideations that produced Mr. Ohenhen’s past criminal behaviour, and that continued medication was essential to prevent relapse into antisocial conduct. The Board’s written reasons carefully recited its mandate, the statutory burden of proof, the principles in the Supreme Court of Canada’s leading decision in Starson v. Swayze, and a summary of the evidence. It then upheld the finding of incapacity on two central grounds: that Mr. Ohenhen attributed his criminal past to youthful immaturity rather than mental illness, contrary to Dr. Klukach’s opinion, and that his compliance with medication was driven by a desire to avoid police involvement and incarceration rather than an acceptance that the medication was needed to avert relapse.

The patient’s evidence on capacity and consequences

In his own testimony, Mr. Ohenhen said he had pleaded NCR in 2007 to “play the justice system” and avoid a second prison term, maintaining that his past offending stemmed from youth, not schizophrenia. He denied a link between his mental illness and his criminal conduct, yet acknowledged the criminality and harm he had caused, and indicated that as an older, more mature man he did not want to reoffend. He also testified that he had remained on medication out of fear his residential carers would contact police, not because he believed the medication was responsible for his stability. Crucially for the capacity analysis, he outlined a specific plan to reduce his medication gradually—titrating the dosage downward rather than stopping abruptly—and testified that if his symptoms returned, he would resume the drug regimen. Because the medication was administered by injection and required a prescription, the only reasonable reading of his evidence was that any dosage reduction would take place under medical supervision.

The Board’s reasoning and its legal misstep

Although the Board used language echoing the statutory test—finding an inability to appreciate the consequences of stopping medication—its analysis, as later reconstructed by the court, turned on Mr. Ohenhen’s refusal to accept schizophrenia as the cause of his past offences and his refusal to embrace the clinical narrative that medication was the sole reason he had stayed out of trouble. The Board accepted Dr. Klukach’s diagnosis and opinion over the patient’s lay explanation, and effectively treated his denial of a mental disorder and his non-medical motives for compliance as evidence of incapacity to appreciate foreseeable consequences. It rejected his evidence about a gradual dose reduction and willingness to return to medication on relapse, reasoning that “his overall testimony” showed he never accepted that his past offences were the product of psychotic illness. In doing so, the Board blurred the line between disagreement with medical advice and genuine cognitive inability to appreciate the possibility of harmful outcomes. The Board also appeared influenced by institutional concerns: the desire to avoid conflicts in his residence (including disputes about television programming) and to prevent nuisance behaviour like obsessive letter-writing to outdated addresses. While such behaviour is understandably worrisome for care staff, the court later emphasized that the statute does not exist to secure peace, order, and institutional convenience, or to maintain a “drugged” baseline state to suppress nuisance conduct. Its purpose is to safeguard patient autonomy in medical decision-making, subject only to a narrow, strictly applied capacity test.

Appellate framework and standard of review

On appeal under s. 80 of the Health Care Consent Act, the Superior Court’s authority extended to questions of law and fact, and the court possessed all the Board’s powers, including the power to substitute its own opinion or remit the matter. In light of the statutory right of appeal, the judgment followed the approach in Vavilov: questions of law are reviewed on a correctness standard, whereas questions of fact and mixed fact and law attract a palpable and overriding error threshold, unless an extricable error of law is present. Drawing heavily on Starson v. Swayze, the judge explained that the Board’s application of the statutory capacity test can embed such an extricable legal error when the tribunal, while reciting the correct language, in substance asks the wrong legal question—for example, whether the patient’s decision is wise or in his best interests, rather than whether he is mentally able to appreciate reasonably foreseeable consequences. The court found no reversible error in the Board’s factual findings; rather, the problem lay in the legal framework guiding the Board’s analysis of the second branch of s. 4(1). That misapplication attracted a correctness standard of review.

Patient autonomy and the meaning of “appreciation” under s. 4(1)

The court reaffirmed that the Health Care Consent Act is built on a presumption of capacity and a strong commitment to patient autonomy. A capable person is entitled to refuse treatment, even if the decision appears unwise or contrary to the weight of medical opinion. Under s. 4(1), the “appreciation of the reasonably foreseeable consequences” does not require acceptance of the physician’s diagnosis or endorsement of every clinical conclusion. Instead, it requires a mind that is open to the possibility of negative outcomes, an ability to understand the nature and purpose of the proposed treatment and alternatives, and an understanding that a choice to stop medication could worsen the condition. The evidence showed that Mr. Ohenhen recognized a link between his mental stability and his medication: he proposed tapering doses, acknowledged that he needed medical assistance to manage dosing, and expressly accepted that if his symptoms returned he should and would resume treatment. Even if he denied that schizophrenia caused his historic offences, his reasoning about not wanting to repeat harmful behaviour and avoiding law-breaking revealed an understanding of the risks associated with stopping medication. The court stressed that disagreeing with diagnosis, questioning medication’s benefit, or holding idiosyncratic views about past criminal proceedings do not in themselves constitute incapacity. The key inquiry is whether the mental disorder so impairs the person that he cannot apply relevant information about treatment and consequences to his own situation. On the evidence, that threshold was not met.

Temporal focus of the capacity assessment

A further legal error lay in the Board’s failure to anchor its analysis to capacity “at the time of the hearing.” Capacity can fluctuate, and the statutory question is whether the person is presently able to appreciate the foreseeable consequences of a treatment decision while in his current, medicated, and relatively stable state. The Board gave undue weight to speculative future scenarios—such as the risk that a decompensated, symptomatic Mr. Ohenhen might later be unable to recognize the need to resume medication—and to historical debates about how he originally came into the mental health system. The court observed that nothing in the Act authorizes maintaining involuntary treatment as a prophylactic simply because the person might later become incapable. If his condition worsens and he loses capacity in future, the physician can reassess capacity and engage the statutory process then; what cannot be done is to pre-emptively curtail decision-making rights on the basis of possible future incapacity.

Outcome and implications

In the result, the Superior Court allowed the appeal, set aside the Consent and Capacity Board’s decision confirming incapacity, and declared that Mr. Ohenhen is currently capable of consenting to or refusing antipsychotic treatment. The court declined to remit the matter because the patient’s own evidence—his plan to slowly reduce doses and his stated intention to return to medication in the event of relapse—demonstrated beyond serious dispute that he appreciated the existence of adverse consequences if his decision proved wrong. At the same time, the judge cautioned that this was not a “clean bill of health”: Mr. Ohenhen remains at real risk of relapse and is strongly encouraged to work cooperatively with his doctor and residential staff to avoid renewed contact with the criminal justice system. No monetary damages or fixed cost award were ordered in the decision; while the notice of appeal mentioned costs, the factum did not, and the judge left any issue of costs to be resolved by agreement or further written submissions. Thus, the successful party is the appellant, Julius Ohenhen, but the total amount of any monetary award or costs in his favour cannot be determined from this judgment alone.